T1	Condition 0 8	Pregnant
T2	Condition 12 21	lactating
T3	Person 22 27	women
*	OR T1 T2
T4	Condition 30 52	Evolutive skin disease
T5	Qualifier 60 72	testing zone
T6	Qualifier 74 84	lower back
R1	Subsumes Arg1:T5 Arg2:T6	
R2	Has_qualifier Arg1:T4 Arg2:T5	
T7	Procedure 168 191	Systemic corticotherapy
T8	Procedure 195 222	immunosuppressive treatment
*	OR T7 T8
T9	Temporal 223 248	during the previous month
T10	Scope 168 222	Systemic corticotherapy or immunosuppressive treatment
R3	Has_temporal Arg1:T10 Arg2:T9	
T11	Procedure 253 278	local corticoid treatment
T12	Temporal 279 294	the week before
T13	Condition 386 401	Exposure to sun
T14	Condition 386 397;405 418	Exposure to UV radiations
*	OR T14 T13
T15	Temporal 420 452	15 days before the patch testing
T16	Scope 386 418	Exposure to sun or UV radiations
R4	Has_temporal Arg1:T16 Arg2:T15	
T17	Condition 464 494	deprived of their civic rights
T18	Condition 496 506	in custody
T19	Condition 511 532	subject to a tutorial
T20	Condition 511 523;534 543;562 570	subject to a judiciary decision
T21	Condition 511 521;547 570	subject to administrative decision
*	OR T17 T18 T19 T20 T21
T22	Condition 630 656	critical medical situation
T23	Condition 582 613	subject to a protection measure
T24	Qualifier 104 126	clinically significant
T25	Condition 127 134	disease
R5	Has_qualifier Arg1:T25 Arg2:T24	
T26	Qualifier 136 143	chronic
T27	Qualifier 145 154	recurrent
T28	Qualifier 158 164	active
*	OR T27 T28 T26
T29	Scope 136 164	chronic, recurrent or active
R6	Subsumes Arg1:T24 Arg2:T29	
T30	Qualifier 315 320	Local
T31	Qualifier 324 332	systemic
T32	Drug 333 337	drug
T33	Qualifier 348 383	interacts with the outcome measures
*	OR T31 T30
T34	Scope 315 332	Local or systemic
R7	Has_scope Arg1:T32 Arg2:T34	
R8	Has_qualifier Arg1:T32 Arg2:T33	
T35	Reference_point 435 452	the patch testing
R9	Has_index Arg1:T15 Arg2:T35	
T36	Observation 675 693	personal situation
T37	Non-representable 694 789	judged by the investigator as unlikely to be compatible with optimal participation in the study
T38	Non-query-able 800 839	could constitute a risk for the patient
*	OR T37 T38
T39	Scope 694 839	judged by the investigator as unlikely to be compatible with optimal participation in the study, or which could constitute a risk for the patient
R10	Has_scope Arg1:T36 Arg2:T39	
T40	Observation 842 860	Linguistic barrier
T41	Condition 864 885	psychological profile
T42	Negation 886 896	preventing
T43	Informed_consent 914 938	signing the consent form
R11	Has_negation Arg1:T43 Arg2:T42	
*	OR T41 T40
T44	Scope 842 885	Linguistic barrier or psychological profile
R12	AND Arg1:T44 Arg2:T43	
T45	Competing_trial 992 1031	participation in another clinical trial
T46	Temporal 949 987	still in an exclusion period following
R13	Has_temporal Arg1:T45 Arg2:T46	
T47	Competing_trial 1092 1124	participation in clinical trials
T48	Temporal 1125 1154	during the previous 12 months
T49	Reference_point 1132 1154	the previous 12 months
R14	Has_index Arg1:T48 Arg2:T49	
R15	Has_temporal Arg1:T47 Arg2:T48	
T50	Observation 1050 1087	earned more than 4500€ in indemnities
T51	Non-query-able 1050 1087	earned more than 4500€ in indemnities
R16	AND Arg1:T50 Arg2:T51	
R17	AND Arg1:T50 Arg2:T47	
